• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型对氨基苯磺酰基噁二唑类化合物作为潜在的膜活性抗菌药物,针对耐甲氧西林金黄色葡萄球菌。

Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.

机构信息

Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, Southwest University, Chongqing 400715, PR China.

Institute of Bioorganic & Medicinal Chemistry, Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, Southwest University, Chongqing 400715, PR China.

出版信息

Bioorg Med Chem Lett. 2021 Jun 1;41:127995. doi: 10.1016/j.bmcl.2021.127995. Epub 2021 Mar 26.

DOI:10.1016/j.bmcl.2021.127995
PMID:33775834
Abstract

A class of structurally unique para-aminobenzenesulfonyl oxadiazoles as new potential antimicrobial agents was designed and synthesized from acetanilide. Some target para-aminobenzenesulfonyl oxadiazoles showed antibacterial potency. Noticeably, hexyl derivative 8b (MIC = 1 μg/mL) was more active than norfloxacin against drug resistant MRSA. Compound 8b was able to disturb the membrane effectively and intercalate into deoxyribonucleic acid (DNA) to form a steady 8b-DNA complex, which might be responsible for bacterial metabolic inactivation. Molecular docking indicated that 8b could interact with DNA topoisomerase IV through noncovalent interactions to form a supramolecular complex and hinder the function of this enzyme. These results indicated that hexyl derivative 8b deserved further investigation as a new lead compound.

摘要

一类结构独特的对氨基苯磺酰基噁二唑类化合物被设计并合成出来,它们是从乙酰苯胺衍生而来的新型潜在抗菌剂。一些目标对氨基苯磺酰基噁二唑类化合物表现出抗菌活性。值得注意的是,己基衍生物 8b(MIC = 1 μg/mL)对耐药性 MRSA 的活性比诺氟沙星更强。化合物 8b 能够有效地扰乱细胞膜,并插入脱氧核糖核酸(DNA)中形成稳定的 8b-DNA 复合物,这可能是导致细菌代谢失活的原因。分子对接表明,8b 可以通过非共价相互作用与 DNA 拓扑异构酶 IV 相互作用形成超分子复合物,从而阻碍该酶的功能。这些结果表明,己基衍生物 8b 值得进一步研究,作为一种新的先导化合物。

相似文献

1
Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.新型对氨基苯磺酰基噁二唑类化合物作为潜在的膜活性抗菌药物,针对耐甲氧西林金黄色葡萄球菌。
Bioorg Med Chem Lett. 2021 Jun 1;41:127995. doi: 10.1016/j.bmcl.2021.127995. Epub 2021 Mar 26.
2
Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).新型诺氟沙星-1,3,4-噁二唑杂合子的设计与合成及其作为抗耐甲氧西林金黄色葡萄球菌(MRSA)的抗菌剂。
Eur J Pharm Sci. 2019 Aug 1;136:104966. doi: 10.1016/j.ejps.2019.104966. Epub 2019 Jun 21.
3
Synthesis and antibacterial evaluation of a novel library of 2-(thiazol-5-yl)-1,3,4-oxadiazole derivatives against methicillin-resistant Staphylococcus aureus (MRSA).合成并评价新型 2-(噻唑-5-基)-1,3,4-恶二唑类衍生物库对耐甲氧西林金黄色葡萄球菌(MRSA)的抗菌活性。
Bioorg Chem. 2020 Jan;94:103364. doi: 10.1016/j.bioorg.2019.103364. Epub 2019 Oct 18.
4
Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.新型含 1,3,4-噁二唑连接基的截短侧耳素衍生物的设计、合成、抗 MRSA 的体外和体内评价及分子对接研究。
Bioorg Chem. 2021 Jul;112:104956. doi: 10.1016/j.bioorg.2021.104956. Epub 2021 May 1.
5
New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens.新型利奈唑烷类似物 1,2,4-噁二唑类化合物,对革兰氏阳性多药耐药病原体具有活性。
Eur J Med Chem. 2013 Jul;65:533-45. doi: 10.1016/j.ejmech.2013.03.069. Epub 2013 May 14.
6
Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria.恶二唑类抗菌剂对金黄色葡萄球菌和其他革兰氏阳性菌的活性。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00453-18. Print 2018 Aug.
7
Structure-activity relationship for the oxadiazole class of antibiotics.恶二唑类抗生素的构效关系。
J Med Chem. 2015 Feb 12;58(3):1380-9. doi: 10.1021/jm501661f. Epub 2015 Jan 30.
8
Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibiotics.1,2,4-恶二唑类抗生素构效关系的探索
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4854-4857. doi: 10.1016/j.bmcl.2015.06.044. Epub 2015 Jun 18.
9
A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies.关于作为潜在耐甲氧西林金黄色葡萄球菌(MRSA)活性的恶二唑类似物的关键综述:构效关系研究。
Eur J Med Chem. 2021 Jul 5;219:113442. doi: 10.1016/j.ejmech.2021.113442. Epub 2021 Apr 17.
10
A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV.一种新型氨基噻唑喹啉肟类化合物作为潜在多靶点抗菌药物的探索:设计、合成及对微生物、DNA、HSA 和拓扑异构酶 IV 的作用评价。
Eur J Med Chem. 2019 Oct 1;179:166-181. doi: 10.1016/j.ejmech.2019.06.046. Epub 2019 Jun 19.

引用本文的文献

1
Comprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes.基于咪唑的超分子配合物的药物研究综合洞察
Pharmaceutics. 2023 Apr 27;15(5):1348. doi: 10.3390/pharmaceutics15051348.
2
Novel Thiazolylketenyl Quinazolinones as Potential Anti-MRSA Agents and Allosteric Modulator for PBP2a.新型噻唑基烯酮喹唑啉酮作为潜在的抗耐甲氧西林金黄色葡萄球菌(MRSA)药物和青霉素结合蛋白 2a(PBP2a)的变构调节剂。
Molecules. 2023 May 22;28(10):4240. doi: 10.3390/molecules28104240.
3
Antimicrobial Peptides and Small Molecules Targeting the Cell Membrane of Staphylococcus aureus.
抗微生物肽和小分子靶向金黄色葡萄球菌的细胞膜。
Microbiol Mol Biol Rev. 2023 Jun 28;87(2):e0003722. doi: 10.1128/mmbr.00037-22. Epub 2023 Apr 27.
4
Synthesis and Biological Evaluation of Piperazine Hybridized Coumarin Indolylcyanoenones with Antibacterial Potential.哌嗪杂合香豆素吲哚氰基烯酮的合成及抗菌活性评价。
Molecules. 2023 Mar 9;28(6):2511. doi: 10.3390/molecules28062511.
5
Oxadiazole Schiff Base as Fe Ion Chemosensor: "Turn-off" Fluorescent, Biological and Computational Studies.恶二唑席夫碱作为铁离子化学传感器:“关闭”荧光、生物学及计算研究
J Fluoresc. 2023 Mar;33(2):751-772. doi: 10.1007/s10895-022-03083-1. Epub 2022 Dec 14.
6
Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review.1,3,4-噁二唑和 1,2,4-噁二唑衍生物的合成与药理学研究进展:综述
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2304-2319. doi: 10.1080/14756366.2022.2115036.